AzTrials
AzTrials

HypotensionNCT02366507

Systolic Blood Pressure Measurement in Critically-ill Patients

An observational study of Hypotension and Shock, run by Wake Forest University Health Sciences at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Traditional devices to measure blood pressure include automatic sphygmomanometer (pressure) cuff systems or manual blood pressures obtained by auscultation (listening with a stethoscope). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hypotension, Shock
How many people
12 participants
Where
1 siteUnited States
Study dates
Jul 2014to Sep 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients that present to the Emergency Department with hypotension or suspected shock.

Who may be able to join

  • Age ≥ 18
  • Systolic Blood Pressure < 90 mmHg
  • Normotensive patients with SBP > or = 90 mmHg with suspected hypoperfusion/shock

Who cannot join

  • Patients < 18 years of age
  • Pregnant patients

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Carolinas Medical Center

    Charlotte, North Carolina, 28210

Other trials in United States

About this study

Traditional devices to measure blood pressure include automatic sphygmomanometer (pressure) cuff systems or manual blood pressures obtained by auscultation (listening with a stethoscope). Both these techniques fail to provide accurate and consistent blood pressure in the hypotensive (low blood pressure) state, which is often encountered in emergency departments and intensive care units. Alternately, invasive arterial pressure measurement is time-intensive, painful, expensive, and risks include bleeding, infection, and neurovascular injury.

In clinical practice, the Doppler velocimetry system is occasionally used in hypotensive, critically-ill patients when an immediate systolic blood pressure measurement is vital for clinical and therapeutic management. With a technique similar to that used to obtain a manual blood pressure, the Doppler velocimetry system can be used in place of the auscultation of the brachial pulse to accurately determine the systolic blood pressure. It is currently unknown whether additional information can be obtained by evaluation of the Doppler waveform in healthy vs. critically-ill patients. The goal is this project is to digitally record Doppler waveforms of critically-ill patients in the Emergency Department (ED) via a standard 8MHz (fetal) Doppler probe, correlate the Doppler readings with current blood pressure and heart rate, and determine if waveform shapes and parameters are predictive of hemodynamic compromise.

Read the detailed description

Background/Significance:

Hypotension is common and predicts worse outcomes. Arterial hypotension, defined as an arterial systolic blood pressure (BP) less than 90 mmHg in adults, represents the hallmark of critical illness. Accurate arterial BP measurement is essential to deliver effective treatment, to guide resuscitation, and to assess interventions. Non-traumatic hypotension has been documented in as many as 19% of Emergency Department (ED) patients and those patients with hypotension have a 10-fold increased risk of sudden, unexpected in-hospital death.(1) Early hypotension is associated with increased mortality in survivors of cardiac arrest, stroke, and STEMI,(2-4) stressing the need for a tool to rapidly and accurately identify BP trends in order to effectively direct resuscitative measures. Additionally, Doppler waveforms may provide additional clues of impending hemodynamic deterioration before overt hypotension or shock ensues.

Disadvantages of the current system - The current initial standard for BP measurements in most hospitals is via an automated non-invasive BP device that uses oscillometric technology. This method has numerous limitations including non-continuous monitoring, missing or delays in identifying hypotensive episodes, inaccuracy or inability to measure BP due to various reasons including inaccurate cuff size or severity of hypotension. In one study, 34% of patients had a BP discrepancy of ≥ 20 mmHg with the oscillometric device compared to intra-arterial BP monitoring due to incorrect cuff size.(5) Oscillometric devices are sufficient for use in many clinical situations; however, notable exceptions include patients that are severely hypertensive, hypotensive, with arrhythmias, after trauma, and other critical clinical scenarios, whereby manual auscultatory BP measurement is preferred.(6) Even in non-critically ill patients, validation data of oscillometric measurements has been called into question.(7) The alternative to oscillometric devices is an intra-arterial catheter. Although accurate, intra-arterial catheters are invasive, technically difficult to insert, expensive, time-intensive, painful, and with risks including bleeding, infection, and neurovascular injury. Current guidelines for management of critically ill patients suggest intra-arterial BP measurement is preferred over automatic oscillometric non-invasive BP measurement. Despite this, in a recent survey of intensivists, 73% used non-invasive BP measuring devices in hypotensive patients.(8) For the above reasons, researchers have been investigating newer technology to replace the oscillometric technology; examples include Doppler and photoplethysmographic devices.(9;10) Newer technology- The research and application of Doppler technology for measuring BP is in its infancy and has yet to be fully realized. The benefits of such a device would include an accurate, non-invasive means to measure BP in critically-ill patients. Due the high-risk of missing hypotension, the possibility exists to commercialize the prototype for broader clinical use in non-critically ill patients as well. The accuracy of Doppler velocimetry is one important advantage. In an animal study comparing three indirect BP measuring instruments- a Doppler ultrasonic flowmeter, an oscillometric device, and a photoplethysmograph- to direct arterial pressure in cats, the Doppler and photoplethysmographic devices had the highest overall accuracy. (10) In clinical practice, when the initial automatic oscillometric BP device is unable to obtain a measurement due to hypotension, the manual Doppler technique is a common practice due to its reliability and referenced in one study as the "gold standard".(11) However, accurate systolic BP measurement is only one parameter of the device. The Doppler signal received from the arterial flow through the vessel has incredible potential to identify strength of pulse and other auditory queues. This has been well established in peripheral arterial disease, with descriptive terms used such as monophasic, biphasic, or triphasic pulses identified by Doppler. The novel device has the potential to identify a "sick" pulse as determined by changes in the Doppler waveform prior to hypotension ensues, as often, hypotension is very late in the course of the disease process. To date, there is no automatic sphygmomanometer/Doppler apparatus available.

This project will provide data to further the development of a novel blood pressure monitoring device that will enable non-invasive and near-continuous blood pressure monitoring and other hemodynamic information on critically-ill patients. Data from healthy volunteers using a standard 8MHz (fetal) Doppler probe have already been collected in a companion protocol in place at the University of North Carolina at Charlotte (UNCC).

Research Strategy:

  1. Significance Identification of shock states before overt clinical evidence of shock (i.e., hypotension) is challenging. Determining whether Doppler-measured arterial waveforms can serve as a useful marker to identify hemodynamic compromise before shock ensues is unknown.
  2. Approach Hypothesis: Doppler waveform patterns in critically-ill hypotensive patients have a unique and identifiable pattern.

Objectives:

  1. Doppler waveforms will be collected from the brachial arteries of critically-ill patients that present to the ED with overt evidence of shock. This pilot study will allow us to obtain Doppler measurements in critically-ill patients for comparison to non-critically-ill patients collected previously in an IRB-approved study conducted at UNCC by the Co-PI. Doppler signal measurements will be obtained from 20 critically-ill patients with evidence of shock (i.e., hypotension with SBP < 90) in Emergency Department at Carolinas Medical Center. Eligible patients will be identified from the Code Sepsis clinical protocol alert by PCL currently utilized for other departmental studies or by direct report from the PI while working in the ED. Patients or a legally authorized representative will be approached for informed consent. The 8MHz Doppler probe, (fetal ultrasound probe), will be applied to the brachial artery, and the position adjusted until an adequate signal has been obtained. Doppler wave form data will be collected over the course of a few minutes. It is anticipated that the patients will experience minimal to no discomfort throughout this process. Expected technical difficulties and how we will overcome them: The technical difficulties will include ensuring consistent measurements, as the data will be collected by the investigators and clinical research staff.
  2. Develop a computer algorithm that will distinguish "healthy" from "sick" Doppler waveforms.

Waveform characteristics from the ED patients will be compared to previously collected waveforms from normal volunteers. A computer algorithm will then be developed to identify distinguishing features between these waveforms (independent of blood pressure). We will use a similar power analysis as done by Holt et al.(11)

  1. Algorithm Development: We will use MATLAB (The MathWorks, Inc) to analyze the Doppler signals obtained from the hypotensive/shock patients and compare them to prior obtained healthy patient data in order to identify unique wave characteristics of patients in shock.
  2. Filtering: Optimum filtering software will be designed and perfected by the PIs, as required by the quantified audio piezo-electric signal, to determine most reliable and accurate Doppler waveform.

Sample Size Calculation Previous studies have used a power analysis that determined 18 observation sets (a set being one intra-arterial BP measurement and one Doppler BP measurement) to detect a difference of 10% (deemed clinically significant by investigators) between intra-arterial and Doppler BP with a SD for difference of 7.8 mmHg and an alpha of 0.05 using a two-sided one-sample t-test.

A power analysis was not performed for this pilot study. A sample size of twenty adult subjects (with Doppler recording during of < or = 5 minutes) was chosen to ensure sufficient observations. Further statistical techniques to improve association will be implemented as described in the initial prototype description.

Conditions
Hypotension, Shock
Keywords
hypotension, doppler, shock
Medical subject headings
Hypotension, Shock

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. blood pressure measurements collected under standard of care

    blood pressure measurements collected under standard of care (manual or central line) will be used to compare to Doppler wave form readings.

    Measured: day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2015 (estimated)
  2. Study startJul 2014
  3. Primary completionSep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02366507
Sponsor's protocol ID
BPD-02
Status last verified
Feb 2016
First submitted
25 Jul 2014
Last updated
28 Apr 2022
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hypotension and Shock, run by Wake Forest University Health Sciences at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

blood pressure measurements collected under standard of care (time frame: day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in